Walleye Capital LLC Buys 37,517 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Walleye Capital LLC has significantly increased its stake in Aveanna Healthcare Holdings Inc., boosting its position by 268.9% in the first quarter, resulting in ownership of 51,470 shares worth approximately $279,000.
• In recent analyst reports, Barclays upgraded Aveanna's rating from "equal weight" to "overweight" and raised the target price from $5.50 to $9.50, reflecting positive sentiment towards the stock.
• Insider trading activity saw major shareholders Paul R. Vigano and J.H. Whitney Equity Partners V each selling 750,000 shares at an average price of $5.20, amounting to total transactions of about $3.9 million each.

Walleye Capital LLC boosted its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 268.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 51,470 shares of the company's stock after purchasing an additional 37,517 shares during the quarter. Walleye Capital LLC's holdings in Aveanna Healthcare were worth $279,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in AVAH. Nuveen LLC purchased a new stake in shares of Aveanna Healthcare in the first quarter worth $1,692,000. Millennium Management LLC grew its stake in shares of Aveanna Healthcare by 105.0% in the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after acquiring an additional 205,023 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its stake in shares of Aveanna Healthcare by 50.1% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after acquiring an additional 177,856 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Aveanna Healthcare by 145.9% in the first quarter. Mackenzie Financial Corp now owns 263,662 shares of the company's stock worth $1,429,000 after acquiring an additional 156,439 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Aveanna Healthcare by 71.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 326,144 shares of the company's stock worth $1,768,000 after acquiring an additional 135,574 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Raymond James Financial raised Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price on the stock in a research note on Monday, August 11th. Barclays raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Wall Street Zen raised Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Finally, UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and increased their price objective for the company from $6.75 to $8.00 in a research report on Tuesday, August 19th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare has an average rating of "Moderate Buy" and a consensus price target of $7.50.

Aveanna Healthcare Stock Up 0.3%

NASDAQ:AVAH traded up $0.03 on Tuesday, hitting $8.29. The stock had a trading volume of 129,292 shares, compared to its average volume of 600,020. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of 103.44 and a beta of 2.03. The business's 50-day simple moving average is $5.65 and its two-hundred day simple moving average is $5.21. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $8.41.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 18,500 shares of the firm's stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $4.93, for a total value of $91,205.00. Following the transaction, the insider directly owned 327,869 shares of the company's stock, valued at approximately $1,616,394.17. This trade represents a 5.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 7.00% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.